Mohammed Zghaebi

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Baseline EPOS 2020 eligibility and real-world outcomes of dupilumab in CRSwNP: a longitudinal cohort study.

Baseline EPOS 2020 eligibility and real-world outcomes of dupilumab in CRSwNP: a longitudinal cohort study.

Journal: Rhinology

Published: August 11, 2026

Bispecific nanobodies targeting Bet v 1 and ICAM-1 decrease respiratory epithelial penetration of Bet v 1.

Bispecific nanobodies targeting Bet v 1 and ICAM-1 decrease respiratory epithelial penetration of Bet v 1.

Journal: Frontiers in immunology

Published: April 24, 2026

Dosing Interval Extension of Dupilumab in CRSwNP: Five-Year Real World Outcomes.

Dosing Interval Extension of Dupilumab in CRSwNP: Five-Year Real World Outcomes.

Journal: International forum of allergy & rhinology

Published: November 22, 2025

Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge.

Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge.

Journal: Allergy

Published: October 23, 2025

Allergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract-the B Cell Side.

Allergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract-the B Cell Side.

Journal: Allergy

Published: July 30, 2025

Proteomic profiling and machine learning for endotype prediction in chronic rhinosinusitis.

Proteomic profiling and machine learning for endotype prediction in chronic rhinosinusitis.

Journal: The Journal of allergy and clinical immunology

Published: March 21, 2025

Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry.

Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry.

Journal: Clinical immunology (Orlando, Fla.)

Published: January 19, 2024

Nasal IL-13 production identifies patients with late-phase allergic responses.

Nasal IL-13 production identifies patients with late-phase allergic responses.

Journal: The Journal of allergy and clinical immunology

Published: January 13, 2023

Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment.

Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment.

Journal: Frontiers in immunology

Published: August 18, 2022

Using mass cytometry for the analysis of samples of the human airways.

Using mass cytometry for the analysis of samples of the human airways.

Journal: Frontiers in immunology

Published: August 18, 2022

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE.

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE.

Journal: Frontiers in immunology

Published: October 27, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026